Unseen Signals: Why Some Parents Question When the ByHeart Crisis Began

In the quiet hum of a nursery, a whispered fear now lingers. What parents once saw as warmth and nourishment in a bottle has, for some, become a source of heartache and questions. They say their infants fell ill not just during the recently declared outbreak — but long before it was officially recognized.

Over the past year, a handful of families have traced their children’s illnesses back to ByHeart infant formula, claiming that their babies were treated for botulism months before health authorities sounded the alarm. The parents’ stories now ripple out, demanding attention: how could early cases go unnoticed? Who kept track, and why did the warning come only later?

Between November 2024 and June 2025, California public health officials confirmed that six infants who consumed ByHeart formula were hospitalized for botulism. At the time, they say, there was not enough evidence to tie these cases to a single source. Now, as more than thirty cases across multiple states are under investigation, those same parents feel a sense of being overlooked.

For Amy Mazziotti, the concern became deeply personal. Her son, Hank, began drinking ByHeart formula and was soon hospitalized for infant botulism. Weeks later, as she connected the dots, she found other parents in the same boat. Katie Connolly, another mother, said her daughter fell ill after switching to ByHeart in hopes of better sleep — a heartbreaking irony when the very nourishment meant to soothe them might have been the culprit.

The company, for its part, has responded with cooperation and concern. ByHeart issued a full recall of all its whole-nutrition infant formula products on November 11, 2025. Their founders say they are working with regulators, testing every batch, and investigating every part of their supply chain — from ingredients to canning and distribution.

Meanwhile, federal agencies like the FDA and CDC have urged parents who still have ByHeart formula to stop using it. They’re also recommending caregivers keep any leftover formula for testing if illness appears and to remain alert even if symptoms show up weeks later. Botulism in infants can start subtly — with constipation, weak feeding, or floppy movement — and evolve over time.

For many of these parents, the recall does not erase the months of uncertainty. Some feel their experiences weren’t part of the “official” outbreak because their cases predate the surge flagged in August 2025. The delay in connecting early cases to ByHeart has left wounds — not just physical, but emotional — as they ask: why weren’t their children’s illnesses part of the first wave of investigation?

As investigators continue to test and trace, the company promises transparency. But for the families at the heart of this, answers cannot come soon enough. They seek not only accountability, but assurance that what happened to them will not happen again.

In the meantime, parents and caregivers are urged to discard or set aside any ByHeart formula, label it, and remain vigilant for signs of infant botulism. Health authorities stress that early diagnosis and treatment are critical — though the road ahead may still be uncertain, the collective voice of these families is growing stronger, demanding clarity, care, and change.

AI Image Disclaimer “Illustrations were produced with AI tools and serve as conceptual depictions, not real photographs.”

Source Check Associated Press ABC News FDA (Centers for Disease Control and Prevention) The Washington Post ByHeart (company statement)